Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer
Clinical trial NCT05177042 · COMPLETED
Trial details
- NCT number
- NCT05177042
- Sponsor
- Arvinas Androgen Receptor, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-13
- Primary completion
- 2024-07-02
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.